Find the Perfect Plan for Your Investment Journey
S
Latest price
52 Week Range
HK$9.71 - HK$21.70
Next Earnings Date
-
Next Earnings Date
-
Latest price
Market Cap | HK$28.01B |
EV | HK$28.56B |
Shares Outstanding | 984.87M |
Beta | 0.74 |
Analyst Rating | OUTPERFORM |
Analyst Target Price | HK$14.59 |
P/E 2025E | - |
P/Revenue 2025E | 10.83x |
Revenue | -21.50% |
EPS | -17.60% |
Operating Cash Flow | -30.70% |
Free Cash Flow | 11.40% |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin 2025E | 75.50% |
Net Profit Margin 2025E | -44.48% |
ROE 2025E | -11.99% |
ROCE 2024 | -19.68% |
DPS 2025E | HK$0.00 |
Payout Ratio 2025E | 0.00% |
Div. Yield 2025E | 0.00% |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
S
Shanghai Junshi Biosciences Co., Ltd.
1877
Sector
Healthcare
Industry
Biotechnology
CEO
Data Unavailable
Employees
2,578
Website
www.junshipharma.comIPO Date
2018-12-24
Headquarters
Building 7, 15th Floor, No.6, Lane 100, Pingjiaqiao Road, Pudong New Area, Shanghai 200126, China
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved